SOLUTION NMR


NMR Experiment
Experiment Type Sample Contents Ionic Strength Solvent pH Pressure Temprature (K)
1 2D 1H-15N HSQC 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
2 2D 1H-13C HSQC 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
3 3D HNCO 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
4 3D CBCA(CO)NH 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
5 3D HNCA 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
6 3D 1H-13C arom NOESY 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
7 3D 1H-15N NOESY 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
8 3D 1H-13C NOESY 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
9 3D HBHA(CO)NH 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
10 3D H(C)CH-TOCSY aliphatic 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
11 3D CCH-TOCSY aliphatic 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
12 2D 1H-13C HSQC CT 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
13 2D 1H-13C HSQC arom 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
14 2D HBCBCGCDHD 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail, 90% H2O/10% D2O ? 90% H2O/10% D2O 7.0 ambient 298
NMR Spectrometer Information
Spectrometer Manufacturer Model Field Strength
NMR Refinement
Method Details Software
molecular dynamics restrained molecular dynamics 1
NMR Ensemble Information
Conformer Selection Criteria structures with the lowest energy
Conformers Calculated Total Number 100
Conformers Submitted Total Number 20
Representative Model 1 (lowest energy)
Computation: NMR Software
# Classification Version Software Name Author
1 refinement ? CNS Brunger, Adams, Clore, Gros, Nilges and Read
2 structure solution 2.1 CYANA Guntert, Mumenthaler and Wuthrich
3 processing ? NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4 collection ? TopSpin Bruker Biospin
5 collection ? VnmrJ Varian
6 chemical shift assignment ? ABACUS Lemak, A
7 processing ? MddNMR Orekhov, V. Yu.
8 geometry optimization ? TALOS Cornilescu, Delaglio and Bax
9 data analysis ? Analysis CCPN
10 peak picking ? Analysis CCPN